BetterScholar BetterScholar
8
Role
Title
Level Year L/R
🐜 Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
295 auth. M. Clowse, D. Wallace, R. Furie, M. Petri, M. Pike, P. Leszczyński, C. Neuwelt, K. Hobbs, M. Keiserman, L. Duca, K. Kalunian, C. Gălăţeanu, S. Bongardt, C. Stach, C. Beaudot, ... B. Kilgallen, C. Gordon, A. Batalov, M. Bojincă, R. Djerassi, L. Duca, P. Horák, Z. Kolarov, R. Milasiene, D. Monova, K. Otsa, M. Pileckytė, T. Popova, F. Radulescu, R. Rashkov, S. Rednic, M. Repin, R. Stoilov, D. Tegzová, N. Vezikova, P. Vítek, C. Zainea, Far East, H. Baek, Y. Chen, Y. Chiu, C. Cho, C. Chou, J. Choe, C. Huang, Y. Kang, S. Kang, N. Lai, S. Lee, W. Park, S. Shim, C. Suh, W. Yoo, H. Á. Armengol, F. A. Zapata, M. Santiago, F. Cavalcanti, W. Chahade, L. Costallat, M. Keiserman, J. Alcala, C. Remus, L. Roimicher, M. Abu-Shakra, V. Agarwal, N. Agmon-Levin, J. Kadel, Y. Levy, D. Mevorach, D. Paran, T. Reitblat, I. Rosner, V. Shobha, Z. Sthoeger, D. Zisman, K. Ayesu, S. Berney, J. Box, H. Busch, J. Buyon, J. Carter, J. Chi, M. Clowse, R. Collins, K. Dao, I. Diab, A. Dikranian, M. El-Shahawy, N. Gaylis, J. Grossman, E. Halpert, J. Huff, W. Jarjour, A. Kao, R. Katz, A. Kennedy, M. Khan, A. Kivitz, M. Kohen, T. Lawrence–Ford, J. Lawson, M. Levesque, M. Lowenstein, A. Majjhoo, R. Mcarthur, D. Mclain, J. Merrill, A. Murillo, S. Neucks, G. Niemer, G. Noaiseh, C. Parker, C. Pantojas, D. Pattanaik, M. Petri, P. Pickrell, J. Reveille, A. Roman-Miranda, N. Rothfield, A. Sankoorikal, M. Sayers, A. Singhal, A. Snyder, C. Striebich, Q. Vo, J. V. Von Feldt, D. Wallace, M. Wasko, C. Young, S. Adelstein, S. Hall, G. Littlejohn, D. Nicholls, M. Suranyi, Z. Amoura, B. Bannert, F. Behrens, Lada Perez, K. Chakravarty, F. D. Gonzales, K. Davies, A. Doria, P. Emery, A. Fernández-Nebro, M. Govoni, E. Hachulla, B. Hellmich, F. Houssiau, M. Malaise, J. Margaux, Y. Maugars, S. Muñoz-Fernández, F. Navarro, J. Ordi‐Ros, R. Pellerito, J. Peña-Sagredo, E. Roussou, R. Schmidt, E. Úcar-Angulo, J. Viallard, R. Westhovens, M. Worm, C. Yee, S. Nayiager, H. Reuter, C. Spargo, B. Bazela, M. Brzosko, D. Chudzik, B. Gasztonyi, P. Géher, R. Ionescu, S. Jeka, L. Kemény, E. Kiss, P. Kotyla, L. Kovács, V. Kovalenko, E. Kucharz, B. Kwiatkowska, P. Leszczyński, E. Levchenko, G. Lysenko, M. Majdan, C. Mihailov, S. Nalotov, M. Nedelciu, M. Pavel, T. Raskina, B. Rebrov, E. Rezuș, T. Semen, S. Smakotina, M. Stanislavchuk, M. Stanislav, I. Szombati, G. Szűcs, G. Udrea, J. Zajdel, A. Zoń-Giebel, R. Bonfiglioli, R. Bustamante, E. Klumb, G. Ramírez, C. Neiva, M. Olguin, J.Reyes Gonzaga, A. Scotton, S. Ayala, A. Ximenes, R. Sharma, C. Srikantiah, J. Aelion, C. Aranow, M. Baker, A. Chadha, J. Chao, W. Chatham, A. Chow, C. Clay, S. Cohen‐Gadol, D. Conaway, J. Denburg, A. Escalante, L. Espinoza, J. Fiechtner, I. Fortin, A. Fraser, R. Furie, D. Gladman, D. Goddard, M. Goldberg, R. González-Rivera, J. Gorman, R. Griffin, D. Haaland, D. Halter, A. Hemaiden, K. Hobbs, V. Joshi, S. Lim, K. Kalunian, G. Karpouzas, M. Khraishi, R. Lafyatis, R. Lidman, C. Lue, M. Mohan, P. Mease, C. Mehta, W. Mizutani, A. Nami, J. Nascimento, C. Neuwelt, J. Pappas, J. Pope, A. Porges, G. Roane, D. Rosenberg, S. Ross, C. Saadeh, C. Scoville, Y. Sherrer, M. Solomon, W. Surbeck, G. Valenzuela, P. Waller, R. Alten, C. Baerwald, B. Bienvenu, S. Bombardieri, J. Braun, L. Dival, G. Espinosa, I. F. Fernández, J. Gómez-Reino, C. Gordon, F. Hiepe, N. Hopkinson, D. Isenberg, A. Jacobi, C. Jorgensen, V. Guern, C. Paul, J. Pego-Reigosa, J. R. Heredia, A. Rubbert-Roth, M. Sabbadini, J. Schroeder, A. Schwarting, W. Spieler, G. Valesini, J. Wollenhaupt, A. Z. Mendoza, C. Zouboulis
7 2016
7
🐜
🐜 Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
10 auth. S. Kleinert, H. Tony, A. Krause, M. Feuchtenberger, S. Wassenberg, C. Richter, ... E. Röther, W. Spieler, H. Gnann, B. Wittig
5 2011
5
🐜
🐜 Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids.
11 auth. A. F. Russell, J. Parrino, C. Fisher, W. Spieler, J. Stek, Kathleen E Coll, ... Shu-Chih Su, Jin Xu, Xiaoming Li, K. Schlienger, J. Silber
5 2015
5
🐜
🐜 Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass
8 auth. Peyman Hadji, D. Gamerdinger, W. Spieler, Peter H. Kann, H. Loeffler, K. Articus, ... R. Möricke, V. Ziller
4 2012
4
🐜
🐜 Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass
8 auth. P. Hadji, V. Ziller, D. Gamerdinger, W. Spieler, K. Articus, M. Baier, ... R. Moericke, P. Kann
4 2012
4
🐜
🐢 Training in ergonomics at VDU workplaces
M. Menozzi, A. V. Buol, H. Waldmann, S. Kundig, H. Krueger, W. Spieler
3 1999
3
🐢
🐜 AB0273 Efficacy and safety of add-on golimumab treatment in patients with rheumatoid arthritis receiving concomitant methotrexate or leflunomide
9 auth. J. Wollenhaupt, A. Alonso-Ruiz, W. Spieler, J. Beier, J. Molina, R. Yao, ... M. Govoni, N. Vastesaeger, H. Weng
1 2013
1
🐜
🦁 Comparison of bone mineral density and fracture rates in rheumatoid arthritis and psoriatic arthritis
W. Spieler, K. Schottstedt, W. Keitel, J. Kekow
0 2006
0
🦁